Ultrasound-Guided Serratus Posterior Superior Intercostal Plane Block for Analgesia in Arthroscopic Shoulder Surgery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorBursa City Hospital
About this trial
This study aimed to evaluate the effectiveness of serratus posterior superior intercostal plane (SPSIP) block in managing postoperative pain in patients undergoing arthroscopic shoulder surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Classified as American Society of Anesthesiologists (ASA) physical status I-II-III
Scheduled for elective shoulder arthroscopy surgery
Surgery performed under general anesthesia
Provision of written informed consent
Disqualifiers
Use of anticoagulant or antiplatelet medications
Presence of bleeding diathesis or coagulation disorders
Known allergy or hypersensitivity to local anesthetics or opioid medications
Infection or history of previous surgery at the planned block site
Trial design
Design model
Parallel
Treatments tested in this trial
Group SPSIP: Serratus Posterior Superior İntercostal Plane Block (SPSIP)
Procedure/SurgerySerratus Posterior Superior İntercostal Plane (SPSIP) Block will be performed before the surgery in seated position, under standard sterilization conditions.A linear ultrasound probe will be placed in the sagittal plane along the medial border of the scapula, and the second and third ribs, relevant muscles, and the pleura will be identified. The needle will be advanced into the interfascial plane between the serratus posterior superior and intercostal muscles. After confirmation with salin injection , the block will be performed by injecting 30 mL of 0.25% bupivacaine, and the cranio-caudal spread will be visualized under ultrasound.
Treatment groups
80 Participants
are divided into 2 treatment groupsGroup A: Group SPSIPActive comparator 1 intervention
Group B: Group ControlNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Postoperative 48-Hour PCA Opioid Consumption
Total amount of opioid delivered by the patient-controlled analgesia (PCA) device during the first 48 hours after surgery, recorded in milligrams(mg)
Time frame
Postoperative 0-8, 8-16, 16-24, 24-48 intervalsSecondary outcomes
1
QoR-15 Recovery Score
The investigators will use the Turkish version of Quality of Recovery (QoR) / QoR-15 questionairre PART A How have you been feeling in the last 24 hours? (0 to 10, where: 0 = none of the time \[poor\] and 10 = all of the time \[excellent\]) Able to breathe easily Been able to enjoy food Feeling rested Have had a good sleep Able to look after personal toilet and hygiene unaided Able to communicate with Getting support from hospital doctors and nurses Able to return to work or usual home activities Feeling comfortable and in control Having a feeling of general well-being PART B Have you had any of the following in the last 24 hours? (10 to 0, where: 10 = none of the time \[excellent\] and 0 = all of the time \[poor\]) Moderate pain Severe pain Nausea or vomiting Feeling worried or anxious Feeling sad or depressed
Time frame
Postoperative 24th and 48th hours2
Dynamic and static NRS scores
Numeric Rating Scale (NRS) (0-10 0: No pain 10: most pain felt) pain scores at rest or movement at predefined postoperative hours
Time frame
0, 2, 4, 8, 16, 24, and 48 hours postoperatively3
Total rescue analgesic dose
Despite the use of patient-controlled analgesia (PCA), if the Numeric Rating Scale (NRS) score is ≥4 at any time point, 0.5 mg/kg intravenous meperidine will be administered as
Time frame
Postoperative 24th and 48th hours4
Time of first request for rescue analgesia,
Despite the use of patient-controlled analgesia (PCA), if the Numeric Rating Scale (NRS) score is ≥4 at any time point, 0.5 mg/kg intravenous meperidine will be administered. The time will be recorded.
Time frame
Postoperative 48-HoursSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov